[HTML][HTML] Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank

NS Abul-Husn, ER Soper, JA Odgis, S Cullina… - Genome Medicine, 2020 - Springer
Background Pathogenic variants in BRCA1 and BRCA2 (BRCA1/2) lead to increased risk of
breast, ovarian, and other cancers, but most variant-positive individuals in the general …

[HTML][HTML] Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank

NS Abul-Husn, ER Soper… - Genome …, 2020 - genomemedicine.biomedcentral …
Pathogenic variants in BRCA1 and BRCA2 (BRCA1/2) lead to increased risk of breast,
ovarian, and other cancers, but most variant-positive individuals in the general population …

Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank.

NS Abul-Husn, ER Soper, JA Odgis, S Cullina… - Genome …, 2019 - europepmc.org
Background Pathogenic variants in BRCA1 and BRCA2 (BRCA1/2) lead to increased risk of
breast, ovarian, and other cancers, but most variant-positive individuals in the general …

Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank

NS Abul-Husn, ER Soper, JA Odgis… - Genome …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Pathogenic variants in BRCA1 and BRCA2 (BRCA1/2) lead to increased risk of
breast, ovarian, and other cancers, but most variant-positive individuals in the general …

Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank

NS Abul-Husn, ER Soper, JA Odgis, S Cullina… - Genome Medicine, 2019 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
Pathogenic variants in< jats: italic> BRCA1</jats: italic> and< jats: italic> BRCA2</jats …

Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank.

NS Abul-Husn, ER Soper, JA Odgis… - Genome …, 2019 - search.ebscohost.com
Background: Pathogenic variants in BRCA1 and BRCA2 (BRCA1/2) lead to increased risk of
breast, ovarian, and other cancers, but most variant-positive individuals in the general …

[HTML][HTML] Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank

NS Abul-Husn, ER Soper, JA Odgis, S Cullina… - Genome …, 2020 - ncbi.nlm.nih.gov
Background Pathogenic variants in BRCA1 and BRCA2 (BRCA1/2) lead to increased risk of
breast, ovarian, and other cancers, but most variant-positive individuals in the general …

Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank

NS Abul-Husn, ER Soper, JA Odgis… - Genome …, 2019 - search.proquest.com
Background Pathogenic variants in BRCA1 and BRCA2 (BRCA1/2) lead to increased risk of
breast, ovarian, and other cancers, but most variant-positive individuals in the general …

Exome Sequencing Reveals a High Prevalence of BRCA1 and BRCA2 Founder Variants in a Diverse Population-Based Biobank

NS Abul-Husn, ER Soper, JA Odgis, S Cullina, D Bobo… - bioRxiv, 2019 - biorxiv.org
Pathogenic variants in BRCA1 and BRCA2 (BRCA1/2) lead to increased risk of breast,
ovarian, and other cancers, but most variant positive individuals in the general population …

[PDF][PDF] Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank

NS Abul-Husn, ER Soper, JA Odgis, S Cullina… - 2019 - genomemedicine.biomedcentral …
Background: Pathogenic variants in BRCA1 and BRCA2 (BRCA1/2) lead to increased risk of
breast, ovarian, and other cancers, but most variant-positive individuals in the general …